RecruitingNCT05022264

Remote Investigation and Assessment of Vital Signs

Sponsor

Vastra Gotaland Region

Enrollment

860 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

body temperature oxygen saturation Blood Pressure Pulse Rate Respiratory Rate

Summary

The vital signs (pulse, systolic and diastolic blood pressure, respiratory rate, oxygen saturation and body temperature) are critical in assessing the severity and prognosis of infections. The devices used today for measuring the vital signs have to be in physical contact with the patients. There is an apparent risk of transferring infections from one patient to the next (or to healthcare professionals). Accurately obtaining vital signs is also important when managing other categories of patients where it may be relevant to obtain some of the vital signs such as pulse and blood pressure. This project aims to evaluate a new camera-based system for contactless measurement of vital signs.

Eligibility

Min Age: 18 Years

Inclusion Criteria17

The same subject can't be enrolled more than once with the exception that subjects in WP1 may also be recruited to WP2.
WP1+WP2:
The patient is attending primary or secondary health care.
The subject has provided informed consent.
Age ≥18 years.
Fluent in Swedish, English, Somali or Arabic (we will translate the patient information and ensure an interpreter can be present for translating questions).
The patient is willing and able to give informed consent ".
The investigator determines that the new study device, and the reference methods, can be used as intended with adequate safety.
The delay in the management of each patient introduced by this study is approximately 15-20 minutes. Patients deemed being in such a severe medical condition that 15-20 minutes of delay is deemed detrimental will not be included.
WP3:
Patients attending primary health care.
The subject has provided informed consent.
Age ≥18 years.
Fluent in Swedish, English, Somali or Arabic (we will translate the patient information and ensure an interpreter can be present for translating questions).
The patient is willing and able to give informed consent .
The investigator determines that the new study device, and the reference methods, can be used as intended with adequate safety.
The delay in the management of each patient introduced by this study is approximately 15-20 minutes. Patients deemed being in such a severe medical condition that 15-20 minutes of delay is deemed detrimental will not be included.

Exclusion Criteria1

Subjects are free to withdraw from the study at any point. Subjects will also be withdrawn from the study in case of unexpected depressed level of consciousness from inclusion up until all investigations are completed (during approximately 15-20 minutes). Any reduction in consciousness will incur that the subject is withdrawn.

Interested in this trial?

Get notified about updates and connect with the research team.